Latest News about BIIB
Recent news which mentions BIIB
From Benzinga
10 Biggest Price Target Changes For Monday
February 07, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
Biogen's Aduhelm Approval, Marketing Comes Under FTC, SEC Probes
February 04, 2022
Tickers
BIIB
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 4, 2022
February 04, 2022
From Benzinga
10 Biggest Price Target Changes For Friday
February 04, 2022
From Benzinga
Biogen's Alzheimer's Drug Clocks Q4 Sales Of Just $1M, FY22 Earnings Guidance Below Consensus
February 03, 2022
Tickers
BIIB
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 03, 2022
From Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
From Benzinga
Forecaster Yves Lamoureux has nailed several big market downturns. Here’s why he’s now turning bullish on stocks.
February 03, 2022
From MarketWatch
Earnings Scheduled For February 3, 2022
February 03, 2022
From Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
February 01, 2022
From Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
From Benzinga
From Motley Fool
From Benzinga
Biogen Sells Biosimilar-Venture Stake To Samsung Biologics For $2.3B
January 28, 2022
Tickers
BIIB
From Benzinga
3 Stocks That Have Been Paying Dividends for a Combined 447 Years
January 28, 2022
From Motley Fool
10 Biggest Price Target Changes For Monday
January 24, 2022
From Benzinga
Is Biogen a Buy?
January 22, 2022
From Motley Fool
3 Clinical Trials to Watch in the First Half of 2022
January 22, 2022
From Motley Fool
10 Biggest Price Target Changes For Tuesday
January 18, 2022
From Benzinga
Where Will Biogen Be in 5 Years?
January 15, 2022
From Motley Fool
4 Biotech Acquisitions We'd Like to See in 2022
January 14, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.